117 related articles for article (PubMed ID: 19017549)
1. Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.
Haworth A; Kearvell R; Greer PB; Hooton B; Denham JW; Lamb D; Duchesne G; Murray J; Joseph D
Radiother Oncol; 2009 Mar; 90(3):299-306. PubMed ID: 19017549
[TBL] [Abstract][Full Text] [Related]
2. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.
Purdy JA; Harms WB; Michalski J; Bosch WR
Strahlenther Onkol; 1998 Oct; 174 Suppl 2():40-2. PubMed ID: 9810337
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.
Tai KH; Duchesne G; Turner S; Kneebone A; See A; Gogna K; Berry M
Australas Radiol; 2004 Dec; 48(4):502-8. PubMed ID: 15601331
[TBL] [Abstract][Full Text] [Related]
5. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
[TBL] [Abstract][Full Text] [Related]
6. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
[TBL] [Abstract][Full Text] [Related]
8. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
[TBL] [Abstract][Full Text] [Related]
9. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
[TBL] [Abstract][Full Text] [Related]
10. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Australasian multicentre dosimetric intercomparison: issues, logistics and recommendations.
Ebert MA; Harrison KM; Cornes D; Howlett SJ; Joseph DJ; Kron T; Hamilton CS; Denham JW
J Med Imaging Radiat Oncol; 2009 Feb; 53(1):119-31. PubMed ID: 19453538
[TBL] [Abstract][Full Text] [Related]
12. Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?
Ebert MA; Bulsara M; Haworth A; Kearvell R; Richardson S; Kennedy A; Spry NA; Bydder SA; Joseph DJ; Denham JW
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):99-108. PubMed ID: 25082363
[TBL] [Abstract][Full Text] [Related]
13. The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT.
Johansson KA; Nilsson P; Zackrisson B; Ohlson B; Kjellén E; Mercke C; Alvarez-Fonseca M; Billström A; Björk-Eriksson T; Björ O; Ekberg L; Friesland S; Karlsson M; Lagerlund M; Lundkvist L; Löfroth PO; Löfvander-Thapper K; Nilsson A; Nyman J; Persson E; Reizenstein J; Rosenbrand HO; Wiklund F; Wittgren L
Radiother Oncol; 2008 May; 87(2):290-9. PubMed ID: 18206256
[TBL] [Abstract][Full Text] [Related]
14. Centre credentialing for Trans Tasman Radiation Oncology Group trial 06.02: multicentre feasibility study of accelerated partial breast irradiation.
Kron T; Willis D; Bignell F; Martland J; Donnell S; May S; Chua BH
J Med Imaging Radiat Oncol; 2009 Aug; 53(4):412-8. PubMed ID: 19695049
[TBL] [Abstract][Full Text] [Related]
15. Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain.
Pollicino CA; Turner SL; Roos DE; O'Brien PC
Radiother Oncol; 2005 Sep; 76(3):264-9. PubMed ID: 16153729
[TBL] [Abstract][Full Text] [Related]
16. Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397).
Mayles WP; Moore AR; Aird EG; Bidmead AM; Dearnaley DP; Griffiths SE; Warrington AP;
Radiother Oncol; 2004 Nov; 73(2):199-207. PubMed ID: 15622611
[TBL] [Abstract][Full Text] [Related]
17. Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.
Budiharto T; Musat E; Poortmans P; Hurkmans C; Monti A; Bar-Deroma R; Bernstein Z; Tienhoven Gv; Collette L; Duclos F; Davis B; Aird E;
Radiother Oncol; 2008 Sep; 88(3):403-10. PubMed ID: 18538427
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance in radiotherapy of prostatic cancer.
Cellini N; Morganti AG; Luzi S; Balducci M; Salvi G
Rays; 1996; 21(4):663-71. PubMed ID: 9122451
[TBL] [Abstract][Full Text] [Related]
19. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
[TBL] [Abstract][Full Text] [Related]
20. Survey of radiation oncology centres in Australia: report of the Radiation Oncology Treatment Quality Program.
Kolybaba M; Kron T; Harris J; O'Brien P; Kenny L
J Med Imaging Radiat Oncol; 2009 Aug; 53(4):382-95. PubMed ID: 19695046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
